Jobs
-
Submit workshop proposals by June 16, 2016 at http://www.rddonline.com/rdd/workshop_reg.php?id=14&sid=6. Podium abstract submissions accepted until August 1, 2016 at http://www.rddonline.com/rdd/speaker_reg.php?id=14. Scientific poster abstract submissions will be due by January 6, 2017. Read more . . .
-
Marina Biotech will pay up to $95 million in milestone payments, plus a “mid-single digit” royalty, in addition to 53 million Marina common shares to acquire Turing Pharmaceutical’s intranasal ketamine program, including all existing product,… Read more . . .
-
Catalent Pharma Solutions. As a member of the inhalation development team, you will utilize your expertise to support the advancement of a variety of pulmonary dosage forms that include pMDIs, DPIs, nasal sprays and solutions/suspensions… Read more . . .
-
On the first morning of RDD 2016, Peter Byron welcomed over 600 OINDP specialists from approximately 30 different countries to this year’s meeting, which offered an optimistic vision of the future of inhaled and nasal… Read more . . .
-
An EMA Pharmacovigilance Risk Assessment Committee (PRAC) review of published data from controlled clinical trials, observational studies, and meta-analyses has concluded that all inhaled corticosteroid (ICS) products appear to carry a similar risk of pneumonia… Read more . . .
-
The FDA has approved Teva’s supplemental NDA for ProAir RespiClick albuterol breath-activated DPI for the treatment or asthma in children aged 4 to 11, the company has announced. The sNDA filing was accepted by the… Read more . . .
-
Glenmark Pharmaceuticals Inc., USA is a subsidiary of Glenmark Pharmaceuticals Ltd., a leading player in the discovery of new molecules — both New Chemical Entities (NCE’s) and New Biological Entities (NBEs’), with eight molecules in… Read more . . .
-
OINDP analysis and development specialist Nanopharm is now offering dissolution testing services using its proprietary UniDose aerosol collection apparatus, the company said. UniDose allows analysts to conduct dissolution testing that is independent of the collected… Read more . . .
-
Sunovion has announced that the GOLDEN-3 and GOLDEN-4 Phase 3 clinical trials of SUN-101 glycopyrrolate inhalation solution for the treatment of moderate-to-very severe COPD both met their primary endpoints. SUN-101, delivered via the PARI eFlow… Read more . . .
-
Aradigm Corporation has announced the first closing of a private placement of $23 million in senior convertible notes that mature in 2021 and warrants to purchase 263,436 shares of common stock at $5.21 per share,… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK